Blue Jet Healthcare (BLUEJET) Q4 23/24 earnings summary

Executive summary

• FY24 net profit rose to ₹1,637.51 million from ₹1,600.27 million; revenue declined to ₹7,115.98 million from ₹7,209.82 million.

• Auditors gave an unmodified opinion, stating the annual results present a true and fair view under applicable Ind AS.

Financial highlights

• FY24 revenue from operations was ₹7,115.98 million vs ₹7,209.82 million; total income was ₹7,404.58 million vs ₹7,449.38 million.

• FY24 profit before tax was ₹2,200.95 million, including a ₹97.43 million exceptional loss; prior-year PBT was ₹2,166.11 million.

• FY24 tax expense was ₹563.44 million vs ₹565.84 million; net profit was ₹1,637.51 million vs ₹1,600.27 million.

• Q4 FY24 revenue was ₹1,839.45 million vs ₹2,172.93 million YoY; net profit was ₹396.54 million vs ₹506.99 million.

• FY24 basic and diluted EPS were ₹9.44 each vs ₹9.23; Q4 EPS was ₹2.29 vs ₹2.92 YoY.

Key financial ratios and metrics

• Net cash generated from operating activities was ₹2,412.57 million in FY24 vs ₹1,415.56 million in FY23.

• Cash and cash equivalents were ₹409.54 million at March 31, 2024 vs ₹654.38 million a year earlier.